bpc 157 safety evidence human studies Multifunctionality and Possible Medical Application of the Peptide—Literature and Patent Review BPC-157: Experimental Peptide Creates Risk
Description
Though in vitro data and in vivo animal data thus far is promising, more information and human trials are needed to evaluate the potential role of methylene blue as a treatment for acute and chronic brain injuries
What is on the horizon
BPC-157 For Knee Pain: Early Reported Outcomes A report on intra-articular BPC-157 for knee pain described high rates of improvement: ~92% with BPC-157 alone, ~75% when combined with thymosin beta-4, and overall pain relief reported in 87.5% of patients
Solicited reactogenicity data in 16 and 17 year-old participants are limited
